PTC Therapeutics, Inc. (PTCT)
USD 49.95
(0.87%)
USD 49.95
(0.87%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 415.02 Million USD | -41.02% |
| 2022 | 703.62 Million USD | 63.09% |
| 2021 | 431.43 Million USD | 2.62% |
| 2020 | 420.43 Million USD | 33.96% |
| 2019 | 313.85 Million USD | 105.12% |
| 2018 | 153.01 Million USD | 5.55% |
| 2017 | 144.97 Million USD | 47.6% |
| 2016 | 98.21 Million USD | 3.81% |
| 2015 | 94.6 Million USD | 0.0% |
| 2014 | - USD | -100.0% |
| 2013 | 48.62 Thousand USD | -99.0% |
| 2012 | 4.88 Million USD | -58.23% |
| 2011 | 11.68 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 421.44 Million USD | 1.55% |
| 2024 Q2 | 395.5 Million USD | -6.15% |
| 2023 Q2 | 702.68 Million USD | 0.22% |
| 2023 Q4 | 415.02 Million USD | -41.08% |
| 2023 FY | 415.02 Million USD | -41.02% |
| 2023 Q3 | 704.35 Million USD | 0.24% |
| 2023 Q1 | 701.17 Million USD | -0.35% |
| 2022 Q2 | 599.46 Million USD | 12.65% |
| 2022 Q3 | 415.02 Million USD | -30.77% |
| 2022 Q4 | 703.62 Million USD | 69.54% |
| 2022 FY | 703.62 Million USD | 63.09% |
| 2022 Q1 | 532.14 Million USD | 23.34% |
| 2021 Q2 | 536.43 Million USD | -0.1% |
| 2021 Q3 | 535.53 Million USD | -0.17% |
| 2021 Q1 | 536.98 Million USD | 27.72% |
| 2021 FY | 431.43 Million USD | 2.62% |
| 2021 Q4 | 431.43 Million USD | -19.44% |
| 2020 Q1 | 314.57 Million USD | 0.23% |
| 2020 Q4 | 420.43 Million USD | 1.47% |
| 2020 Q3 | 414.36 Million USD | 21.31% |
| 2020 Q2 | 341.57 Million USD | 8.58% |
| 2020 FY | 420.43 Million USD | 33.96% |
| 2019 Q4 | 313.85 Million USD | 0.23% |
| 2019 Q2 | 155.68 Million USD | 0.35% |
| 2019 Q3 | 313.14 Million USD | 101.15% |
| 2019 Q1 | 155.13 Million USD | 1.39% |
| 2019 FY | 313.85 Million USD | 105.12% |
| 2018 FY | 153.01 Million USD | 5.55% |
| 2018 Q3 | 150.92 Million USD | 1.38% |
| 2018 Q2 | 148.87 Million USD | 1.36% |
| 2018 Q1 | 146.87 Million USD | 1.32% |
| 2018 Q4 | 153.01 Million USD | 1.38% |
| 2017 Q2 | 141.24 Million USD | 41.39% |
| 2017 Q4 | 144.97 Million USD | 1.31% |
| 2017 FY | 144.97 Million USD | 47.6% |
| 2017 Q1 | 99.89 Million USD | 1.71% |
| 2017 Q3 | 143.09 Million USD | 1.31% |
| 2016 Q1 | 93.36 Million USD | -1.31% |
| 2016 FY | 98.21 Million USD | 3.81% |
| 2016 Q4 | 98.21 Million USD | 1.72% |
| 2016 Q3 | 96.55 Million USD | 1.71% |
| 2016 Q2 | 94.93 Million USD | 1.68% |
| 2015 FY | 94.6 Million USD | 0.0% |
| 2015 Q4 | 94.6 Million USD | 1.51% |
| 2015 Q3 | 93.19 Million USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 FY | - USD | -100.0% |
| 2014 Q1 | 12 Thousand USD | -75.32% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q2 | - USD | -100.0% |
| 2013 Q3 | 84.23 Thousand USD | -96.93% |
| 2013 Q4 | 48.62 Thousand USD | -42.28% |
| 2013 FY | 48.62 Thousand USD | -99.0% |
| 2013 Q1 | 3.83 Million USD | -21.46% |
| 2013 Q2 | 2.74 Million USD | -28.39% |
| 2012 FY | 4.88 Million USD | -58.23% |
| 2012 Q4 | 4.88 Million USD | 0.0% |
| 2011 FY | 11.68 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -292171.831% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -5319.936% |
| XOMA Corporation | 124.45 Million USD | -233.488% |
| Mesoblast Limited | 118.92 Million USD | -248.987% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | -81.083% |
| Aptorum Group Limited | 3.36 Million USD | -12243.159% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -31844.342% |
| HilleVax, Inc. | 51.19 Million USD | -710.708% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -1557.32% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -1887.27% |
| Precision BioSciences, Inc. | 31.26 Million USD | -1227.319% |
| Dyadic International, Inc. | 136.92 Thousand USD | -302995.765% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -262574.684% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -14350.766% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -7508.176% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -193837.383% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -7488.7% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | -80.893% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -3240.518% |
| IGM Biosciences, Inc. | 40.5 Million USD | -924.604% |
| Opthea Limited | 200.62 Million USD | -106.863% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -701.595% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -7585.667% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -4129.349% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -6631.971% |
| NextCure, Inc. | 6.6 Million USD | -6183.512% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -66624.115% |
| Ovid Therapeutics Inc. | 46 Million USD | -802.197% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -1854.075% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -1273.531% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -568.588% |
| Senti Biosciences, Inc. | 37.66 Million USD | -1001.858% |
| Apollomics, Inc. | 4.66 Million USD | -8804.227% |
| PureTech Health plc | 25.51 Million USD | -1526.787% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -130411.321% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -3098.413% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -390.146% |
| ChromaDex Corporation | 3.27 Million USD | -12564.815% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -298.366% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -989.193% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -296.112% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -300.852% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -309.36% |
| Fortress Biotech, Inc. | 88.59 Million USD | -368.469% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -557.03% |
| Celcuity Inc. | 37.44 Million USD | -1008.324% |
| ContextLogic Inc. | 6 Million USD | -6817.1% |
| GH Research PLC | 343 Thousand USD | -120898.834% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -6227.58% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -1121591.892% |
| ImmuCell Corporation | 11.96 Million USD | -3367.42% |
| Amarin Corporation plc | 8.73 Million USD | -4650.212% |
| TG Therapeutics, Inc. | 110.79 Million USD | -274.589% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -612.112% |
| Acelyrin, Inc. | 1.19 Million USD | -34659.296% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -1368.651% |
| Novavax, Inc. | 280.63 Million USD | -47.888% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -198.515% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 92.84% |
| AnaptysBio, Inc. | 17.81 Million USD | -2229.774% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -7589.939% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -3023.784% |
| AbCellera Biologics Inc. | 77.38 Million USD | -436.348% |
| CorMedix Inc. | 667.63 Thousand USD | -62063.887% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -3688.462% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 84.645% |
| Aptose Biosciences Inc. | 1 Million USD | -40999.578% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -4794562.662% |
| Soligenix, Inc. | 3.49 Million USD | -11776.342% |
| Century Therapeutics, Inc. | 48.17 Million USD | -761.568% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -260.356% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -92011.121% |
| Kura Oncology, Inc. | 17.2 Million USD | -2312.942% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -5909.644% |
| Ardelyx, Inc. | 55.98 Million USD | -641.356% |
| Ainos, Inc. | 5.96 Million USD | -6859.371% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -349.002% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -19203.535% |
| Prothena Corporation plc | 11.83 Million USD | -3406.768% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -2869.987% |
| Autolus Therapeutics plc | 52.96 Million USD | -683.556% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -1544.644% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -891.865% |
| Celularity Inc. | 65.41 Million USD | -534.431% |
| Rallybio Corporation | 392 Thousand USD | -105773.98% |
| GRI Bio, Inc. | 14 Thousand USD | -2964371.429% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | -22.687% |
| INmune Bio, Inc. | 10.43 Million USD | -3876.487% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -131.047% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -6925.933% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -508012.145% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -50093.991% |
| Humacyte, Inc. | 58.1 Million USD | -614.257% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -617.145% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 13.688% |
| Immunocore Holdings plc | 84.03 Million USD | -393.89% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -22297.518% |
| Verastem, Inc. | 41.55 Million USD | -898.691% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -3549.543% |
| Histogen Inc. | 4.62 Million USD | -8879.36% |
| Surrozen, Inc. | 3.37 Million USD | -12182.51% |
| Blueprint Medicines Corporation | 774.12 Million USD | 46.388% |
| Organovo Holdings, Inc. | 1.39 Million USD | -29672.31% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -16540.978% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -715462.069% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -390.644% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -198458.033% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -8170.745% |
| Summit Therapeutics Inc. | 106.09 Million USD | -291.169% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -276.072% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -255588.56% |
| Turnstone Biologics Corp. | 3.21 Million USD | -12813.068% |
| Pulmatrix, Inc. | 8.75 Million USD | -4639.904% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -167926.721% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -325.201% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -2896.578% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -259.81% |
| Cytokinetics, Incorporated | 755.77 Million USD | 45.086% |
| Exelixis, Inc. | 189.94 Million USD | -118.499% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -1255.674% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -274.14% |
| Evogene Ltd. | 1.13 Million USD | -36369.772% |
| Replimune Group, Inc. | 75.86 Million USD | -447.03% |
| PDS Biotechnology Corporation | 23.85 Million USD | -1640.033% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -752235.72% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -14796.841% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -516564.177% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -849144.936% |
| BioLineRx Ltd. | 11.59 Million USD | -3480.588% |
| Avid Bioservices, Inc. | 207.83 Million USD | -99.691% |
| Insmed Incorporated | 1.2 Billion USD | 65.529% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -19476.698% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -806.705% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -638401.538% |
| MediWound Ltd. | 6.71 Million USD | -6084.265% |
| MiMedx Group, Inc. | 48.09 Million USD | -762.858% |
| OmniAb, Inc. | 25.56 Million USD | -1523.669% |
| Alector, Inc. | 38.91 Million USD | -966.411% |
| Seres Therapeutics, Inc. | 213.93 Million USD | -93.995% |
| Mereo BioPharma Group plc | 5.95 Million USD | -6872.883% |
| Zai Lab Limited | 15.15 Million USD | -2639.265% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 13.253% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -25283.853% |
| Aura Biosciences, Inc. | 19.55 Million USD | -2022.135% |
| Immunic, Inc. | 1.33 Million USD | -31011.394% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -1413.865% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -1207.91% |
| Veracyte, Inc. | 12.63 Million USD | -3186.033% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 35.641% |
| FibroGen, Inc. | 170.45 Million USD | -143.481% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4470.268% |
| Allakos Inc. | 41.46 Million USD | -900.907% |
| scPharmaceuticals Inc. | 40.26 Million USD | -930.634% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -3735.376% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -274751.656% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -25303.337% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -203432.914% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -9695.28% |
| Precigen, Inc. | 7.09 Million USD | -5747.908% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 75.267% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -5572.079% |
| Incyte Corporation | 38.28 Million USD | -983.987% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -137913.528% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -861.443% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -3626.217% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -14796.841% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | -73.919% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -1493.618% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -118818.625% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -1443.938% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -820.786% |
| Agenus Inc. | 350.24 Million USD | -18.496% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -388170.294% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -29147.78% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -817.468% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -861.398% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -760.532% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -253015.566% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 51.099% |
| UroGen Pharma Ltd. | 100.21 Million USD | -314.14% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -40295.835% |
| Sutro Biopharma, Inc. | 182.74 Million USD | -127.102% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -2923853.783% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -135974.098% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -105773.439% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -5972.07% |
| Chimerix, Inc. | 2.14 Million USD | -19257.556% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -42554.265% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -1067.27% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -240253.732% |
| Pluri Inc. | 29.61 Million USD | -1301.547% |
| Cue Biopharma, Inc. | 14.69 Million USD | -2724.267% |
| MeiraGTx Holdings plc | 89.26 Million USD | -364.942% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -1943815.691% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -8409.863% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -571.368% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -298.695% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -5900.087% |
| NLS Pharmaceutics AG | 1.63 Million USD | -25303.337% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -1215.538% |
| Nutriband Inc. | 241.28 Thousand USD | -171906.548% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -7491.476% |
| Vor Biopharma Inc. | 35.66 Million USD | -1063.842% |
| Roivant Sciences Ltd. | 499.74 Million USD | 16.953% |
| ProKidney Corp. | 4.41 Million USD | -9304.623% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -33752.039% |
| Daré Bioscience, Inc. | 5.31 Million USD | -7703.962% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 76.146% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -73355.929% |
| Bicycle Therapeutics plc | 44.95 Million USD | -823.183% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -966.357% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -477.974% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -371.921% |
| Atai Life Sciences N.V. | 16.47 Million USD | -2418.973% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -16832.953% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -61385.333% |
| MediciNova, Inc. | 215.92 Thousand USD | -192107.516% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -16534.309% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -32811.72% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -36273.883% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -122.687% |
| Biomea Fusion, Inc. | 10.29 Million USD | -3930.944% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -642.989% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -11460.613% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4430.357% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -2728.887% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -3285.756% |
| bluebird bio, Inc. | 330.32 Million USD | -25.641% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -3218.615% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -25444.557% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 63.398% |
| BioAtla, Inc. | 2.46 Million USD | -16770.976% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -336.314% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -7383.339% |
| DBV Technologies S.A. | 14.38 Million USD | -2785.933% |
| Fortress Biotech, Inc. | 88.59 Million USD | -368.469% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -4112.607% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -2092.077% |
| aTyr Pharma, Inc. | 15.09 Million USD | -2649.427% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -1871.807% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -127016.355% |
| Galecto, Inc. | 249 Thousand USD | -166577.108% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -25334.801% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 72.318% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -291.298% |
| Entera Bio Ltd. | 390 Thousand USD | -106316.923% |
| Travere Therapeutics, Inc. | 404.78 Million USD | -2.53% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -6585.341% |
| Xencor, Inc. | 83.43 Million USD | -397.43% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -24501.423% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -8904.686% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -33801.093% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -4313.292% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -253015.566% |
| Portage Biotech Inc. | 47 Thousand USD | -882934.043% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -32811.72% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -17071.121% |
| OncoCyte Corporation | 2.86 Million USD | -14365.877% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -275565.874% |
| Purple Biotech Ltd. | 351 Thousand USD | -118141.026% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -13037.892% |
| Onconetix, Inc. | 9.88 Million USD | -4098.215% |
| MacroGenics, Inc. | 33.97 Million USD | -1121.707% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -20304.435% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -7833.971% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -2944.275% |
| Aditxt, Inc. | 18.21 Million USD | -2178.111% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -1452.195% |
| Curis, Inc. | 2.79 Million USD | -14754.188% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -19325.973% |
| Adagene Inc. | 22.3 Million USD | -1760.53% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -2380.581% |
| BeiGene, Ltd. | 930.18 Million USD | 55.382% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | -97.499% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -51239.062% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 32.071% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -545986.842% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -16487.77% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -406.025% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | -101.551% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -8836.822% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 84.529% |
| ADMA Biologics, Inc. | 141.41 Million USD | -193.475% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -585.099% |
| Clene Inc. | 32.16 Million USD | -1190.464% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -16226.751% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -2101.379% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -18807.79% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -719.044% |
| Adicet Bio, Inc. | 20.92 Million USD | -1883.493% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | -114.826% |
| Absci Corporation | 15.95 Million USD | -2500.902% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -2612.056% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -1945.168% |
| Surrozen, Inc. | 3.37 Million USD | -12182.51% |
| Generation Bio Co. | 97.89 Million USD | -323.954% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -126047.72% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -1410.009% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -1540.549% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -1591.085% |
| Invivyd, Inc. | 2.16 Million USD | -19069.792% |
| Cingulate Inc. | 3.13 Million USD | -13138.051% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -676.243% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -11777930.666% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -82755.563% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -7387.39% |
| Jaguar Health, Inc. | 35.86 Million USD | -1057.351% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -658671.429% |
| 2seventy bio, Inc. | 256.67 Million USD | -61.694% |
| Clearside Biomedical, Inc. | 43 Million USD | -865.154% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -68726.866% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -625.507% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -7295.129% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -86140.065% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -1367.975% |
| Innoviva, Inc. | 449.07 Million USD | 7.582% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -1952.653% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -508.275% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -2313.363% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -233.247% |
| Evaxion Biotech A/S | 10.86 Million USD | -3718.199% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -397.699% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -454.055% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -6288.947% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -1012158.537% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -1437.703% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -89152.903% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -1413.092% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -3963.703% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -11567.866% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -26589.775% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -32838.571% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -2773.345% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -45708.609% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -702.324% |
| ImmunityBio, Inc. | 883.67 Million USD | 53.034% |
| Korro Bio, Inc. | 33.2 Million USD | -1149.815% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -484.741% |
| Kineta, Inc. | 1.31 Million USD | -31412.984% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -176905.259% |
| BioVie Inc. | 6.11 Million USD | -6690.961% |
| Codexis, Inc. | 22.36 Million USD | -1755.777% |
| Celularity Inc. | 65.41 Million USD | -534.431% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -108261.88% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -184931.654% |
| Kodiak Sciences Inc. | 181.63 Million USD | -128.498% |
| Cibus, Inc. | 24.62 Million USD | -1585.659% |
| Annexon, Inc. | 31.35 Million USD | -1223.636% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -17621.008% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 71.447% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -453.103% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -10533.513% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -2476.56% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -272.254% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -801.466% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -1192.191% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -42034.619% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -3522.467% |
| Alkermes plc | 290.73 Million USD | -42.753% |
| Arcellx, Inc. | 97.62 Million USD | -325.123% |
| Moolec Science SA | 2.64 Million USD | -15589.25% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -19212.517% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -6474.149% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -1465.368% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -13279.304% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -17178.351% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -23848.413% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -614.257% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -1356.896% |
| Geron Corporation | 85.89 Million USD | -383.156% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -811.945% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 93.235% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -359996.83% |
| Notable Labs, Ltd. | 2.04 Million USD | -20155.051% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -1126.799% |
| Structure Therapeutics Inc. | 5.45 Million USD | -7510.965% |
| IN8bio, Inc. | 4.89 Million USD | -8382.036% |
| 89bio, Inc. | 27.1 Million USD | -1431.009% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -103656.5% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -672.745% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -16375.824% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -30918.386% |
| Liquidia Corporation | 3.5 Million USD | -11747.731% |
| Mustang Bio, Inc. | 2.49 Million USD | -16514.331% |
| Immunovant, Inc. | 138 Thousand USD | -300643.478% |
| Vericel Corporation | 88.14 Million USD | -370.855% |
| Quantum-Si incorporated | 15.3 Million USD | -2612.056% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -4658.927% |
| XOMA Corporation | 124.45 Million USD | -233.488% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -151369.343% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -508012.145% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3026.137% |
| Vaxcyte, Inc. | 29.22 Million USD | -1320.155% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -3706.53% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -204346.305% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -1908.741% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -25007.441% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -32838.571% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -102884.119% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -40115.698% |
| PepGen Inc. | 20.1 Million USD | -1964.395% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -72204.181% |
| United Therapeutics Corporation | 700 Million USD | 40.711% |
| Solid Biosciences Inc. | 26.26 Million USD | -1480.148% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -42034.619% |
| Immuneering Corporation | 4.46 Million USD | -9199.346% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -410816.832% |
| Belite Bio, Inc | 886 Thousand USD | -46742.664% |
| Pharming Group N.V. | 171.54 Million USD | -141.934% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | -73.203% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -1845.647% |
| uniQure N.V. | 138.4 Million USD | -199.855% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -2365.989% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -385.848% |
| Altimmune, Inc. | 671 Thousand USD | -61751.863% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -3026.137% |
| Peak Bio, Inc. | 10.72 Million USD | -3770.859% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -4470.268% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -23656.497% |
| Benitec Biopharma Inc. | 284 Thousand USD | -146035.915% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 6.748% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -143188.807% |
| Compugen Ltd. | 1.35 Million USD | -30619.911% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -197072.299% |
| argenx SE | 20 Million USD | -1975.13% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -870.458% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -390.836% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -1983.359% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -254.139% |
| PolyPid Ltd. | 11.77 Million USD | -3423.44% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -353.789% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -9826.477% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -70844.615% |
| Instil Bio, Inc. | 86.05 Million USD | -382.286% |
| Elevation Oncology, Inc. | 30.13 Million USD | -1277.131% |
| Immunome, Inc. | 1.65 Million USD | -25053.091% |
| Verona Pharma plc | 51.32 Million USD | -708.56% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -4144.488% |
| Shattuck Labs, Inc. | 4.2 Million USD | -9776.868% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -114548.066% |
| Design Therapeutics, Inc. | 3.05 Million USD | -13507.41% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -158306.87% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -2816.967% |
| Achilles Therapeutics plc | 4.61 Million USD | -8892.979% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | -11.052% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -1278.87% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -11123.392% |
| Beam Therapeutics Inc. | 173.17 Million USD | -139.66% |
| Moolec Science SA | 2.64 Million USD | -15589.25% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -87273.895% |
| AEON Biopharma, Inc. | 278 Thousand USD | -149189.928% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -5808.685% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -123788.358% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -447.08% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -579.179% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -1273.838% |
| Athira Pharma, Inc. | 1.58 Million USD | -26084.606% |
| HCW Biologics Inc. | 6.45 Million USD | -6332.739% |
| XOMA Corporation | 124.45 Million USD | -233.488% |
| NeurAxis, Inc. | 224.26 Thousand USD | -184964.657% |
| Lumos Pharma, Inc. | 6.58 Million USD | -6202.597% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -4144.488% |
| 180 Life Sciences Corp. | 1.32 Million USD | -31339.72% |
| Nektar Therapeutics | 230.4 Million USD | -80.132% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -1983.359% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -2329.877% |
| Arvinas, Inc. | 3.4 Million USD | -12106.647% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -26589.775% |
| Palisade Bio, Inc. | 369 Thousand USD | -112373.171% |
| Nutriband Inc. | 241.28 Thousand USD | -171906.548% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -25334.801% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -50145.278% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -99906.265% |
| Merus N.V. | 12.16 Million USD | -3312.481% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -223.159% |
| Neurogene Inc. | 16.25 Million USD | -2453.221% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | -34.687% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -1354.14% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -2904.387% |
| Rezolute, Inc. | 2.22 Million USD | -18527.738% |
| Clene Inc. | 32.16 Million USD | -1190.464% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -236985.911% |
| BeyondSpring Inc. | 3.99 Million USD | -10288.636% |
| Synlogic, Inc. | 17.27 Million USD | -2302.466% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -31825.077% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -1185688.571% |
| Peak Bio, Inc. | 10.72 Million USD | -3770.859% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -699.311% |
| Krystal Biotech, Inc. | 8.09 Million USD | -5027.577% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -134.457% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -5781.054% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -303739.114% |
| MannKind Corporation | 382.37 Million USD | -8.538% |
| Ikena Oncology, Inc. | 10.73 Million USD | -3765.021% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -101373.35% |
| Gossamer Bio, Inc. | 212.46 Million USD | -95.339% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -238420.69% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -4430.357% |
| Legend Biotech Corporation | 328.67 Million USD | -26.274% |
| Mural Oncology plc | 15 Million USD | -2665.181% |
| Disc Medicine, Inc. | 2.1 Million USD | -19653.736% |
| Champions Oncology, Inc. | 7.43 Million USD | -5485.814% |
| REGENXBIO Inc. | 89.29 Million USD | -364.807% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -48458.261% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -74952.353% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -7565.792% |
| Vaxart, Inc. | 26.51 Million USD | -1465.309% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -2550.677% |
| Cellectis S.A. | 92.85 Million USD | -346.971% |
| Longeveron Inc. | 2.04 Million USD | -20234.444% |
| Repare Therapeutics Inc. | 3.41 Million USD | -12070.85% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 70.288% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -790.767% |
| Revolution Medicines, Inc. | 87.94 Million USD | -371.921% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -239799.422% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -10399.013% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -130823.028% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -237057.714% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 48.661% |
| Denali Therapeutics Inc. | 52.24 Million USD | -694.445% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -2781.032% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -30105.677% |
| Cingulate Inc. | 3.13 Million USD | -13138.051% |
| Passage Bio, Inc. | 26.29 Million USD | -1478.406% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -6126.947% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -101622.059% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -46323.49% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -1918.511% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -16832.089% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -13189.337% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -51074.599% |
| OmniAb, Inc. | 25.56 Million USD | -1523.669% |
| Anew Medical, Inc. | 1.6 Million USD | -25758.318% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -1302.927% |
| Lipocine Inc. | 17.16 Thousand USD | -2417621.077% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -3466.128% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -1098.527% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -6925.933% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -625.913% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -204346.305% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -7935.353% |
| Ocugen, Inc. | 6.94 Million USD | -5879.34% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -2837.405% |
| Q32 Bio Inc. | 1.31 Million USD | -31389.074% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -61659.821% |
| Alumis Inc. Common Stock | 32.58 Million USD | -1173.867% |
| Equillium, Inc. | 824 Thousand USD | -50267.233% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -4471.274% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -137871.317% |
| Dominari Holdings Inc. | 3.02 Million USD | -13606.275% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -439141.377% |
| vTv Therapeutics Inc. | 529 Thousand USD | -78354.82% |
| Bio-Techne Corporation | 419.53 Million USD | 1.075% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -476.457% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | -114.411% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -2357.52% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -1723.328% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -6750.875% |
| Nkarta, Inc. | 88.33 Million USD | -369.811% |
| BioCardia, Inc. | 1.31 Million USD | -31460.913% |
| Iterum Therapeutics plc | 19.5 Million USD | -2027.357% |